Related Experiment Videos
Abuse Deterrent Formulations of Prescription Opioids--Reply
Theodore J Cicero1, Matthew S Ellis1
1Department of Psychiatry, Washington University in St Louis, St Louis, Missouri.
JAMA Psychiatry
|July 9, 2015
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Trends in XTAMPZA ER and other oxycodone misuse and abuse during COVID-19: A mosaic approach.
Journal of opioid management·2025
Angiotensin-Converting Enzyme in Patients With Early-Stage Psychosis.
JAMA psychiatry·2026
Changes in Characteristics Associated With ADHD and ASD Diagnoses Over Time.
JAMA psychiatry·2026
Potential for Genomics to Help Guide Preventive Strategies in Psychiatry.
JAMA psychiatry·2026
Intrathecal Morphine Versus Transversus Abdominis Plane Block in Robotic Colorectal Surgery.
The Journal of surgical research·2026
Blood fentanyl concentrations and clinical presentation among patients with substance use disorders in the emergency department.
Legal medicine (Tokyo, Japan)·2026
Medication Preparation Errors Involving Very Small and Difficult-to-measure Volumes in a Pediatric Hospital: A 14-year Descriptive Study.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Current clinical applications and future developments of platinum-based anticancer drugs.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry·2026